urea has been researched along with Airflow Obstruction, Chronic in 14 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this study was to determine the intrapulmonary profile of high-dose (750 mg) levofloxacin in patients during an acute exacerbation of chronic bronchitis (AECB)." | 9.16 | Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis. ( Baughman, RP; Nicolau, DP; Sutherland, C; Winget, D, 2012) |
| " We examined the effect of 1 week treatment with BAY 19-8004 (5 mg once daily), a novel orally administered PDE4 inhibitor, on trough FEV1 and markers of inflammation in induced sputum in patients with asthma or chronic obstructive pulmonary disease (COPD)." | 9.10 | Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). ( Benschop, N; Gauw, SA; Grootendorst, DC; Hiemstra, PS; Rabe, KF; Sterk, PJ, 2003) |
| "Low-intensity exercise suppresses whole-body protein and urea turnover in COPD patients with emphysema and needs to be considered when maximal anabolism is targeted through a combination of exercise and nutrition." | 7.72 | Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema. ( Deutz, NE; Engelen, MP; Mostert, R; Schols, AM; Wouters, EF, 2003) |
| " The purpose of this study was to determine the intrapulmonary profile of high-dose (750 mg) levofloxacin in patients during an acute exacerbation of chronic bronchitis (AECB)." | 5.16 | Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis. ( Baughman, RP; Nicolau, DP; Sutherland, C; Winget, D, 2012) |
| " We examined the effect of 1 week treatment with BAY 19-8004 (5 mg once daily), a novel orally administered PDE4 inhibitor, on trough FEV1 and markers of inflammation in induced sputum in patients with asthma or chronic obstructive pulmonary disease (COPD)." | 5.10 | Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). ( Benschop, N; Gauw, SA; Grootendorst, DC; Hiemstra, PS; Rabe, KF; Sterk, PJ, 2003) |
| "Low-intensity exercise suppresses whole-body protein and urea turnover in COPD patients with emphysema and needs to be considered when maximal anabolism is targeted through a combination of exercise and nutrition." | 3.72 | Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema. ( Deutz, NE; Engelen, MP; Mostert, R; Schols, AM; Wouters, EF, 2003) |
| "In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of the airways by inducing a reduction in the production of bronchodilatory nitric oxide (NO) that results from its competition with constitutive (cNOS) and inducible (iNOS) NO synthases for their common substrate." | 2.44 | Arginase and pulmonary diseases. ( Maarsingh, H; Meurs, H; Pera, T, 2008) |
| "In patients with COPD, only serum creatinine was higher (81." | 1.48 | Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis. ( Döme, B; Fábián, K; Fejes, D; Kakuk, T; Moldvay, J; Pipek, O; Prés, L; Puskás, R; Rojkó, L; Szállási, Z; Szegedi, Z, 2018) |
| "Hospitalization for exacerbation of COPD is associated with a high risk of mortality." | 1.37 | Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score. ( Chang, CL; Hancox, RJ; Karalus, NC; McLachlan, JD; Mills, GD; Sullivan, GD, 2011) |
| "Chronic obstructive pulmonary disease (COPD) has a rising global incidence and acute exacerbation of COPD (AECOPD) carries a high health-care economic burden." | 1.37 | Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD. ( Andrews, NP; Asiimwe, AC; Brims, FJ; Chauhan, AJ; Higgins, BR; Kilburn, SA; Prytherch, DR, 2011) |
| "Urea is a non-volatile molecule ex vivo and EBC urea depends on its concentrations in plasma." | 1.35 | Urea in exhaled breath condensate of uraemics and patients with chronic airway diseases. ( Acampa, O; Andreoli, R; Bertorelli, G; Corradi, M; David, S; Folesani, G; Franchini, I; Goldoni, M; Manini, P, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kaviani, A | 1 |
| Khansari Nejad, N | 1 |
| Akour, A | 1 |
| AlMuhaissen, SA | 1 |
| Nusair, MB | 1 |
| Al-Tammemi, AB | 1 |
| Mahmoud, NN | 1 |
| Jalouqa, S | 1 |
| Alrawashdeh, MN | 1 |
| Shanahan, JP | 1 |
| Moore, CM | 1 |
| Kampf, JW | 1 |
| Szymczak, NK | 1 |
| Guo, J | 1 |
| Wang, H | 1 |
| Luo, Y | 1 |
| An, H | 1 |
| Zhang, Z | 2 |
| Liu, G | 1 |
| Li, J | 1 |
| Metcalfe, GD | 1 |
| Smith, TW | 1 |
| Hippler, M | 1 |
| Ayala Izurieta, JE | 1 |
| Márquez, CO | 1 |
| García, VJ | 1 |
| Jara Santillán, CA | 1 |
| Sisti, JM | 1 |
| Pasqualotto, N | 1 |
| Van Wittenberghe, S | 1 |
| Delegido, J | 1 |
| Kubo, Y | 1 |
| Kitagawa, Y | 1 |
| Miyazaki, T | 1 |
| Sohda, M | 1 |
| Yamaji, T | 1 |
| Sakai, M | 1 |
| Saeki, H | 1 |
| Nemoto, K | 1 |
| Oyama, T | 2 |
| Muto, M | 1 |
| Takeuchi, H | 1 |
| Toh, Y | 1 |
| Matsubara, H | 1 |
| Mano, M | 1 |
| Kono, K | 1 |
| Kato, K | 1 |
| Yoshida, M | 1 |
| Kawakubo, H | 1 |
| Booka, E | 1 |
| Yamatsuji, T | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Ishikawa, H | 1 |
| Ishihara, R | 1 |
| Tsushima, T | 1 |
| Kawachi, H | 1 |
| Kojima, T | 1 |
| Kuribayashi, S | 1 |
| Makino, T | 1 |
| Matsuda, S | 1 |
| Doki, Y | 1 |
| Ma, P | 1 |
| Tang, X | 1 |
| Zhang, L | 2 |
| Wang, X | 1 |
| Wang, W | 1 |
| Zhang, X | 1 |
| Wang, S | 2 |
| Zhou, N | 1 |
| Dodd, J | 1 |
| Jordan, R | 1 |
| Makhlina, M | 1 |
| Pesco Koplowitz, L | 1 |
| Koplowitz, B | 1 |
| Barnett, K | 1 |
| Yang, WH | 1 |
| Spana, C | 1 |
| Buchanan, SW | 1 |
| Mafa-Attoye, T | 1 |
| Dunfield, K | 1 |
| Thevathasan, NV | 1 |
| Isaac, ME | 1 |
| Wu, X | 2 |
| Huang, JW | 1 |
| Su, BK | 1 |
| Yuan, L | 1 |
| Zheng, WQ | 1 |
| Zhang, H | 2 |
| Zheng, YX | 1 |
| Zhu, W | 1 |
| Chou, PT | 1 |
| Manso, AP | 1 |
| De Morais, DC | 1 |
| Yamamoto, K | 1 |
| Owen, G | 1 |
| de Carvalho, RM | 1 |
| Palma-Dibb, RG | 1 |
| Brown, JC | 1 |
| Yang, S | 1 |
| Mire, EF | 1 |
| Miele, L | 1 |
| Ochoa, A | 1 |
| Zabaleta, J | 1 |
| Katzmarzyk, PT | 1 |
| Moi, CT | 1 |
| Bhowmick, S | 1 |
| Qureshi, M | 1 |
| Wang, K | 1 |
| Feng, B | 1 |
| Yang, Y | 1 |
| Chen, Y | 1 |
| Wang, Y | 2 |
| Yang, L | 1 |
| Jiang, K | 1 |
| James, TD | 1 |
| Chaturvedi, V | 1 |
| Postiglione, WM | 1 |
| Chakraborty, RD | 1 |
| Yu, B | 1 |
| Tabiś, W | 1 |
| Hameed, S | 1 |
| Biniskos, N | 1 |
| Jacobson, A | 1 |
| Zhou, H | 1 |
| Greven, M | 1 |
| Ferry, VE | 1 |
| Leighton, C | 1 |
| Wu, F | 1 |
| Lei, H | 1 |
| Chen, G | 1 |
| Chen, C | 1 |
| Song, Y | 1 |
| Cao, Z | 1 |
| Zhang, C | 2 |
| Zhou, J | 1 |
| Lu, Y | 1 |
| Pappone, C | 1 |
| Santinelli, V | 1 |
| Mecarocci, V | 1 |
| Tondi, L | 1 |
| Ciconte, G | 1 |
| Manguso, F | 1 |
| Sturla, F | 1 |
| Vicedomini, G | 1 |
| Micaglio, E | 1 |
| Anastasia, L | 1 |
| Pica, S | 1 |
| Camporeale, A | 1 |
| Lombardi, M | 1 |
| Shieh, PB | 1 |
| Elfring, G | 1 |
| Trifillis, P | 1 |
| Santos, C | 1 |
| Peltz, SW | 1 |
| Parsons, JA | 1 |
| Apkon, S | 1 |
| Darras, BT | 1 |
| Campbell, C | 1 |
| McDonald, CM | 1 |
| Galaviz, KI | 1 |
| Shah, NS | 1 |
| Gutierrez, M | 1 |
| Collins, LF | 1 |
| Lahiri, CD | 1 |
| Moran, CA | 1 |
| Szabo, B | 1 |
| Sumitani, J | 1 |
| Rhodes, J | 1 |
| Marconi, VC | 1 |
| Nguyen, ML | 1 |
| Cantos, VD | 1 |
| Armstrong, WS | 1 |
| Colasanti, JA | 1 |
| Tanwar, Y | 1 |
| Singh, C | 1 |
| Chakrabarty, S | 1 |
| Fábián, K | 1 |
| Puskás, R | 1 |
| Kakuk, T | 1 |
| Prés, L | 1 |
| Fejes, D | 1 |
| Szegedi, Z | 1 |
| Rojkó, L | 1 |
| Szállási, Z | 1 |
| Döme, B | 1 |
| Pipek, O | 1 |
| Moldvay, J | 1 |
| Koskela, HO | 1 |
| Salonen, PH | 1 |
| Niskanen, L | 1 |
| Folesani, G | 1 |
| Corradi, M | 1 |
| Goldoni, M | 1 |
| Manini, P | 1 |
| Acampa, O | 1 |
| Andreoli, R | 1 |
| Bertorelli, G | 1 |
| David, S | 1 |
| Franchini, I | 1 |
| Chang, CL | 1 |
| Sullivan, GD | 1 |
| Karalus, NC | 1 |
| Mills, GD | 1 |
| McLachlan, JD | 1 |
| Hancox, RJ | 1 |
| Esther, CR | 1 |
| Lazaar, AL | 1 |
| Bordonali, E | 1 |
| Qaqish, B | 1 |
| Boucher, RC | 1 |
| Asiimwe, AC | 1 |
| Brims, FJ | 1 |
| Andrews, NP | 1 |
| Prytherch, DR | 1 |
| Higgins, BR | 1 |
| Kilburn, SA | 1 |
| Chauhan, AJ | 1 |
| Nicolau, DP | 1 |
| Sutherland, C | 1 |
| Winget, D | 1 |
| Baughman, RP | 1 |
| Engelen, MP | 1 |
| Deutz, NE | 1 |
| Mostert, R | 1 |
| Wouters, EF | 1 |
| Schols, AM | 1 |
| Grootendorst, DC | 1 |
| Gauw, SA | 1 |
| Benschop, N | 1 |
| Sterk, PJ | 1 |
| Hiemstra, PS | 1 |
| Rabe, KF | 1 |
| Esposito, C | 1 |
| De Mauri, A | 1 |
| Vitulo, P | 1 |
| Oggionni, T | 1 |
| Cornacchia, F | 1 |
| Valentino, R | 1 |
| Grosjean, F | 1 |
| Torreggiani, M | 1 |
| Dal Canton, A | 1 |
| Maarsingh, H | 1 |
| Pera, T | 1 |
| Meurs, H | 1 |
| Kirkham, S | 1 |
| Sheehan, JK | 1 |
| Knight, D | 1 |
| Richardson, PS | 1 |
| Thornton, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Non-Invasive Doppler Ultrasound For Assessing Patients With Chronic Obstructive Pulmonary Disease: A Prospective Observational Study[NCT02329522] | 200 participants (Anticipated) | Observational | 2014-02-28 | Active, not recruiting | |||
| Phase I/II Randomized, Double-blind, Placebo-controlled Cross-over Study of Prednisone on Airway Inflammatory Response to Inhaled Wood Smoke.[NCT03861390] | Phase 1/Phase 2 | 14 participants (Anticipated) | Interventional | 2019-03-22 | Recruiting | ||
| Phase I/II Randomized Cross-over Study of Hypertonic Saline on Airway Inflammatory Response to Inhaled Wood Smoke[NCT03851406] | 14 participants (Anticipated) | Interventional | 2019-08-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for urea and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes | 2021 |
Arginase and pulmonary diseases.
Topics: Animals; Arginase; Arginine; Asthma; Cystic Fibrosis; Disease Models, Animal; Humans; Hypertension, | 2008 |
2 trials available for urea and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; | 2012 |
Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Asthma; B | 2003 |
10 other studies available for urea and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Comparison of Serum Uric Acid Levels in Patients with Stable Chronic Obstructive Pulmonary Disease and Patients with Acute Exacerbation.
Topics: Creatinine; Cross-Sectional Studies; Humans; Hypoxia; Pulmonary Disease, Chronic Obstructive; Urea; | 2022 |
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Comorbidity; Creat | 2018 |
Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease.
Topics: Acute Disease; Aged; Aged, 80 and over; Asthma; Blood Glucose; C-Reactive Protein; Comorbidity; Diab | 2013 |
Urea in exhaled breath condensate of uraemics and patients with chronic airway diseases.
Topics: Adult; Asthma; Breath Tests; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Pulmonary Disease, | 2008 |
Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Confusion; Disease Progression; Female; Hospi | 2011 |
Elevated airway purines in COPD.
Topics: Adenosine; Adenosine Monophosphate; Aged; Biomarkers; Breath Tests; Case-Control Studies; Exhalation | 2011 |
Elevated airway purines in COPD.
Topics: Adenosine; Adenosine Monophosphate; Aged; Biomarkers; Breath Tests; Case-Control Studies; Exhalation | 2011 |
Elevated airway purines in COPD.
Topics: Adenosine; Adenosine Monophosphate; Aged; Biomarkers; Breath Tests; Case-Control Studies; Exhalation | 2011 |
Elevated airway purines in COPD.
Topics: Adenosine; Adenosine Monophosphate; Aged; Biomarkers; Breath Tests; Case-Control Studies; Exhalation | 2011 |
Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD.
Topics: Aged; Aged, 80 and over; Algorithms; Biomarkers; Carbon Dioxide; Decision Support Techniques; Decisi | 2011 |
Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema.
Topics: Aged; Body Composition; Body Mass Index; Emphysema; Exercise; Humans; Kinetics; Male; Middle Aged; P | 2003 |
Risk factors for chronic renal dysfunction in lung transplant recipients.
Topics: Adult; Age Factors; Blood Pressure; Comorbidity; Female; Humans; Hypertension, Pulmonary; Kidney Fai | 2007 |
Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
Topics: Asthma; Blotting, Western; Cystic Fibrosis; Dose-Response Relationship, Drug; Electrophoresis, Agar | 2002 |